Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine

Neuropharmacology

Volumn 58, Issue 8, 2010, Pages 1237-1245

  Reichel, Carmela M ^a,b   Murray, Jennifer E ^a,c   Barr, Jessica D ^a   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c University of Cambridge   (United Kingdom)

Author keywords

Chantix ; Extinction learning; Pavlovian conditioning; Smoking cessation; Tobacco

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; CYTISINE; EPIBATIDINE; NICOTINE; NORNICOTINE; SODIUM CHLORIDE; SUCROSE; VARENICLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DRUG DOSE COMPARISON; DRUG MECHANISM; EVOKED RESPONSE; INSTRUMENTAL CONDITIONING; LOW DRUG DOSE; MALE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; TASK PERFORMANCE;

ANIMALS; BENZAZEPINES; CONDITIONING, CLASSICAL; DISCRIMINATION (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; GENERALIZATION (PSYCHOLOGY); ISOXAZOLES; LIGANDS; MALE; NICOTINE; NICOTINIC AGONISTS; PYRROLIDINES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77952886658     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.03.005     Document Type: Article

References (50)

1. Alessi S.M., Roll J.M., Reilly M.P., Johanson C.-E. Establishment of a diazepam preference in human volunteers following differential-conditioning history of placebo versus diazepam choice. Exp. Clin. Psychopharmacol. 2002, 10:77-83.
2. Bardo M.T., Schnur P. The motivational impact of nicotine and its role in tobacco use: final comments and priorities. The Motivational Impact of Nicotine and its Role in Tobacco use: The 55th Nebraska Symposium on Motivation 2009, 199-205. Springer, New York, NY. R.A. Bevins, A.R. Caggiula (Eds.).
3. Besheer J., Palmatier M.I., Metschke D.M., Bevins R.A. Nicotine as a signal for the presence or absence of sucrose reward: a pavlovian drug appetitive conditioning preparation in rats. Psychopharmacology 2004, 172:108-117.
4. Bevins R.A. Altering the motivational function of nicotine through conditioning processes. The Motivational Impact of Nicotine and its Role in Tobacco use: The 55th nebraska Symposium on Motivation 2009, 111-129. Springer, New York, NY. R.A. Bevins, A.R. Caggiula (Eds.).
5. Bevins R.A., Jensen H.C., Hinze T.S., Besheer J. Taste quality and extinction of a conditioned taste aversion in rats. Anim. Learn. Behav. 1999, 27:358-366.
6. Bevins R.A., Besheer J., Pickett K.S. Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacol. Biochem. Behav. 2001, 68:135-145.
7. Bevins R.A., Palmatier M.I. Extending the role of associative learning processes in nicotine addiction. Behav. Cogn. Neurosci. Rev. 2004, 3:143-158.
8. Bouton M.E. Context and retrieval in extinction and in other examples of interference in simple associative learning. Current Topics in Animal Learning: Brain, Emotion, and Cognition 1991, 25-53. Erlbaum, Hillsdale, NJ. L. Dachowski, C.F. Flaherty (Eds.).
9. Bouton M.E. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol. Psychiatry 2002, 52:976-986.
10. Chandler C.J., Stolerman I.P. Discriminative stimulus properties of the nicotinic agonist cytosine. Psychopharmacology 1997, 129:257-264.
11. Conklin C.A. Environments as cues to smoke: implications for human extinction-based research and treatment. Exp. Clin. Psychopharmacol. 2006, 14:12-19.
12. Damaj M.I., Creasy K.R., Grove A.D., Rosecrans J.A., Martin B.R. Pharmacological effects of epibatidine optical enantiomers. Brain Res. 1994, 664:34-40.
13. Damaj M.I., Creasy K.R., Welch S.P., Rosecrans J.A., Aceto M.D., Martin B.R. Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Psychopharmacology 1995, 120:483-490.
14. Davis M., Myers K.M. The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biol. Psychiatry 2002, 52:998-1007.
15. Delamater A.R. Experimental extinction in Pavlovian conditioning: behavioural and neuroscience perspectives. Q. J. Exp. Psychol. B 2004, 57:97-132.
16. Esson C.M., Leeder S.R. The Millennium Development Goals and Tobacco Control: An Opportunity for Global Partnership 2004, World Health Organization, France.
17. Farwell B.J., Ayres J.J.B. Stimulus-reinforcer and response-reinforcer relations in the control of conditioned appetitive headpoking (" goal-tracking" ) in rats. Learn. Motiv. 1979, 10:295-312.
18. Goldberg S.R., Risner M.E., Stolerman I.P., Reavill C., Garcha H.S. Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats. Psychopharmacology 1989, 97:295-302.
19. Hahan B., Sharples C.G.V., Wonnacott S., Shoaib M., Stolerman I.P. Attentional effects of nicotinic agonists in rats. Neuropharmacology 2003, 44:1054-1067.
20. Hall S.M., Humfleet G.L., Reus V.I., Muñoz R.F., Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am. J. Psychiatry 2004, 161:2100-2107.
21. LaSage M.G., Shelley D., Ross J.T., Carroll F.I., Corrigall W.A. Effects of the nicotinic receptor partial agonists varenicline and cytosine on the discriminative stimulus effects of nicotine in rats. Pharmacol. Biochem. Behav. 2009, 91:461-467.
22. Lee D.C., Myers C.S., Taylor R.C., Moolchan E.T., Berlin I., Heishman S.J. Consistency of subjective responses to imagery-induced tobacco craving over multiple sessions. Addict. Behav. 2007, 32:2130-2139.
23. Murray J.E., Bevins R.A. Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus. Eur. J. Pharmacol. 2007, 561:91-104.
24. Murray J.E., Bevins R.A. The conditional stimulus effects of nicotine vary as a function of training dose. Behav. Pharmacol. 2007, 18:707-716.
25. Murray J.E., Bevins R.A. Acquired appetitive responding to intravenous nicotine reflects a Pavlovian conditioned association. Behav. Neurosci. 2009, 123:97-108.
26. Murray J.E., Wells N.R., Lyford G.D., Bevins R.A. Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats. Psychopharmacology 2009, 205:655-665.
27. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
28. Palmatier M.I., Wilkinson J.L., Bevins R.A. Stimulus properties of nicotine, amphetamine, and chlordiazepoxide as positive features in a pavlovian appetitive discrimination task in rats. Neuropsychopharmacology 2005, 30:731-741.
29. Palmatier M.I., Bevins R.A. Facilitation by drug states does not depend on acquired excitatory strength. Behav. Brain Res. 2007, 176:292-301.
30. Papke R.L., Dwoskin L.P., Crooks P.A. The pharmacologic activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery. J. Neurochem. 2007, 101:160-167.
31. Pavlov I.P. Conditioned Reflexes 1927, Oxford University Press, London.
32. Perkins K.A., DiMarco A., Grobe J.E., Scierka A., Stiller R.L. Nicotine discrimination in male and female smokers. Psychopharmacology 1994, 116:407-413.
33. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharm Rev. 2008, 33:56-72.
34. Rauhut A.S., Thomas B.L., Ayres J.J.B. Treatments that weaken Pavlovian conditioned fear and thwart its renewal in rats: implications for treating human phobias. J. Exp. Psychol. Anim. Behav. Process 2001, 27:99-114.
35. Reichel C.M., Wilkinson J.L., Bevins R.A. Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task with rats. Behav. Pharmacol. 2007, 18:755-765.
36. Rescorla R.A. Inhibitory associations between S and R in extinction. Anim. Learn. Behav. 1993, 21:327-336.
37. Rescorla R.A. Spontaneous recovery after Pavlovian conditioning with multiple outcomes. Anim. Learn. Behav. 1997, 25:99-107.
38. Rescorla R.A. Retraining of extinguished Pavlovian stimuli. J. Exp. Psychol. Anim. Behav. Process 2001, 27:115-124.
39. Robleto K., Poulos A.M., Thompson R.F. Effects of a corneal anesthetic on extinction of the classically conditioned nictitating membrane response in the rabbit (Oryctolagus cuniculus). Behav. Neurosci. 2004, 18:1433-1438.
40. Rose J.E. New findings on nicotine addiction and treatment. The motivational impact of nicotine and its role in tobacco use: The 55th Nebraska symposium on motivation 2009, 131-141. Springer, New York, NY. R.A. Bevins, A.R. Caggiula (Eds.).
41. Schröter M., Collins S.E., Frittrang T., Buchkremer G., Batra A. Randomized controlled trial of relapse prevention and a standard behavioral intervention with adult smokers. Addict. Behav. 2006, 31:1259-1264.
42. Skinner D.M., Goddard M.J., Holland P.C. What can nontraditional features tell us about conditioning and occasion setting?. Occasion Setting: Associative Learning and Cognition in Animals 1998, 113-144. American Psychological Association, Washington, DC. N.A. Schmajuk, P.C. Holland (Eds.).
43. Smith J.W., Mogg A., Rafi E., Peacey E., Pullar I.A., Szekeres P., Tricklebank M. Ligands selective for α4β2 but not α4β3 or α7 nicotinic receptors generalize to the nicotine discriminative stimulus in the rat. Psychopharmacology 2007, 190:157-170.
44. Smith J.W., Stolerman I.P. Recognising nicotine: the Neurobiological basis of nicotine discrimination. Nicotine Psychopharmacology, Handbook of Experimental Psychology 2009, 192:295-333. Springer-Verlag Berlin Heidelberg. J.E. Henningfield (Ed.).
45. Stolerman I.P. Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology 1989, 97:131-138.
46. Stolerman I.P., Garcha H.S., Pratt J.A., Kumar R. Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 1984, 84:413-419.
47. Struthers A.M., Wilkinson J.L., Dwoskin L.P., Crooks P.A., Bevins R.A. Mecamylamine, dihydro-β-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine. Pharmacol. Biochem. Behav. 2009, 94:319-328.
48. Wiley J.L., James J.R., Rosecrans J.A. Discriminative stimulus properties of nicotine: approaches to evaluating potential nicotinic receptor agonist and antagonists. Drug Dev. Res. 1996, 38:222-230.
49. Wilkinson J.L., Murray J.E., Li C., Wiltgen S.M., Penrod R.D., Berg S.A., Bevins R.A. Interoceptive Pavlovian conditioning with nicotine as the conditional stimulus varies as a function of number of conditioning trials and unpaired sucrose deliveries. Behav. Pharmacol. 2006, 17:161-172.
50. Wooters, T.E., Bevins, R.A., Bardo, M.T., (in press). Neuropharmacology of the interoceptive stimulus properties of nicotine. Curr Drug Abuse Rev.